Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules
-17h 50m
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-18h 9m
-18h 14m
Primary Offering Prospectus (Form 424B2)
-18h 47m
Primary Offering Prospectus (Form 424B2)
-18h 52m
Primary Offering Prospectus (Form 424B2)
-18h 53m
Primary Offering Prospectus (Form 424B2)
-18h 53m
Primary Offering Prospectus (Form 424B2)
-18h 53m
Primary Offering Prospectus (Form 424B2)
-18h 54m
Primary Offering Prospectus (Form 424B2)
-18h 55m